Behavioral Health Business: 5 Serious Mental Illness Companies to Watch in 2022 and Beyond

By Laura Lovett on August 30, 2022

Serious mental illnesses (SMIs) are extremely costly and can lead to negative health outcomes, a fact that makes this corner of the behavioral health world ripe for innovation. Specializing in SMI treatment, however, comes with a number of high-stakes challenges.

SMIs – conditions such as schizophrenia, severe bipolar disorder and major depression – impact roughly 5% of the U.S. population. Additionally, the economic cost of SMI is more than $300 billion each year, according to SMI Advisor.

Read the full piece via Behavioral Health Business >> https://bhbusiness.com/2022/08/30/serious-mental-illnesses-smis-are-extremely-costly-and-can-lead-to-negative-health-outcomes-a-fact-that-makes-this-corner-of-the-behavioral-health-world-ripe-for-innovation/